Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant
medication. It is sold as a racemate by Pfizer under the tradenames Petinutin ...
Each Celontin capsule contains 300 mg methsuximide, USP. Also contains
starch, NF. The capsule contains colloidal silicon dioxide, NF; D&C yellow No.
Easy to read patient leaflet for methsuximide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Medscape - Indication-specific dosing for Celontin (methsuximide), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
May 1, 2009 ... Methsuximide is used to control absence seizures (petit mal; a type of seizure in
which there is a very short loss of awareness during which the ...
Oct 30, 2007 ... Description, Mesuximide (or methsuximide) is an anticonvulsant medication. It is
sold by Pfizer under the name Petinutin. [Wikipedia]. Structure.
For this reason, methsuximide should be administered with extreme caution to
patients with known liver or renal disease. Periodic urinalysis and liver function ...
May 16, 2016 ... Methsuximide is an anti-epileptic medication, also called an anticonvulsant.
Methsuximide suppresses the paroxysmal three cycle per second spike and
wave activity associated with lapses of consciousness which is common in
Consumer information about the medication METHSUXIMIDE - ORAL (Celontin),
includes side effects, drug interactions, recommended dosages, and storage ...